Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
about
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysisAn alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activatorThe receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexesThe urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motilitySuppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascadeThe urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodelingEffective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin LAccessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitorProcessing of complex between urokinase and its type-2 inhibitor on the cell surfaceExtracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancerModulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptorElevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.Synthesis and characterization of an (111)In-labeled peptide for the in vivo localization of human cancers expressing the urokinase-type plasminogen activator receptor (uPAR)Targeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia.Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways.The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis.Differential protease expression by cutaneous squamous and basal cell carcinomas.Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombinFunctional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseTargeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis.A deficiency of uPAR alters endothelial angiogenic function and cell morphology.The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.Binding of tissue plasminogen activator to cultured human endothelial cells.The low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.Differentiation-Associated Downregulation of Poly(ADP-Ribose) Polymerase-1 Expression in Myoblasts Serves to Increase Their Resistance to Oxidative Stress.Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expressionPorphyromonas gingivalis-derived RgpA-Kgp Complex Activates the Macrophage Urokinase Plasminogen Activator System: IMPLICATIONS FOR PERIODONTITISRole of plasminogen activator in pemphigus vulgaris.Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase.Binding of urokinase to specific receptor sites on human breast cancer membranesThe urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system.Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface.Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
P2860
Q24299135-99B7E63A-5C91-4425-8697-6CDDB3D12691Q24316221-313F2FB5-2719-4ED5-B9C3-B441480ABB07Q24678932-5BC4C6B1-13A3-4F3D-83E3-F813C45294A0Q28212178-3653EE86-61C3-4DE6-9D60-DE5744B85B42Q28218095-A60148D0-EED5-47B6-8005-F7D6B674E7F7Q28257803-974F098D-2D99-4AFB-B819-53CE1D28A674Q28290438-EB446045-762B-4F79-ABBF-BE61D473DBCCQ28647054-CB874B78-D9A5-444B-B920-B066C35DB942Q29306421-C22F198E-AB9E-45AB-87AD-A1A9AA045D8CQ30164226-3EEAF071-C98C-469D-82F1-8AC4ACD8D125Q30493647-B1D31C49-6971-42CA-B852-00354732C40DQ31038443-ED393DF6-D147-4CEB-BCAE-2DD9E551748EQ33886514-CC050729-A105-4F96-87DA-F83553ADCE6DQ33887878-32ED606B-9BD4-4141-A22F-599DDF4B9DEEQ33895912-38E07B7D-1041-4532-B01C-6D100040625BQ33912826-3CE64456-948B-4E50-A326-4FF97B828D4DQ34075984-B9D54770-310D-44E4-9572-F66AC2ECE65FQ34103424-F6BD06D2-DCF2-4648-9639-8617C6978EC2Q34165118-65C1D350-8558-47F6-8FD7-EFD0A15A4201Q34202408-347E10F5-A7AE-4175-A643-5C467B1115D3Q34256090-4B5062A4-55F2-44D7-9788-1F69FB8A63DFQ34290829-632DF4DA-2A35-405A-BED4-B03BDF6E90F9Q34330943-6AE493DA-E76E-43E1-B3E6-29E62B6C9C69Q34777224-4E6ABE51-B95C-45FD-B83C-D7744C2E2CE6Q35019176-B9DD8FBE-C476-4FF0-A334-43A1ABE89D20Q35240620-571B83F7-2BCB-41AA-AC46-20D7ACA5088AQ35583510-842950F6-88E1-4DB0-873C-4FAE08D44E6AQ35589734-38863696-7731-42E3-985E-240616BC9D73Q35617966-7F9FF8DC-7FDA-4B7F-92D5-41648F580F60Q35720459-965E90FF-D009-4C98-A89D-0EFCA4CCDA02Q35750875-BB439D38-57ED-4F77-A4CA-B4482EA536D1Q35783075-E0DBDC1C-47C1-4D89-BFB6-E06E2A88A82EQ35815953-85925EAA-B803-4CE0-9713-5DC2D39862B5Q35819933-E0946C4B-DBA0-4F68-B06A-88225DE4141CQ35976072-05C44638-879B-47D8-AF65-DDB335A6A837Q35992977-EAE3413A-5D99-4687-BF59-7F0E7A744542Q36027615-C4F324BF-51DE-40ED-B0F3-F495865BD48EQ36046670-2C41533D-CE59-430F-AEA4-E4420E147C56Q36216106-84A8402A-8EFB-48C3-87A7-C602B81420CBQ36216416-7B9985A3-FA1F-418D-8FFD-10D804D9EBAE
P2860
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1985
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@en
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@nl
type
label
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@en
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@nl
prefLabel
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@en
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@nl
P2093
P2860
P356
P1476
Differentiation-enhanced bindi ...... ic receptor on U937 monocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.82.15.4939
P407
P577
1985-08-01T00:00:00Z